Lambova Sevdalina, Batalov Anastas, Sapundzhiev Lyubomir, Müller-Ladner Ulf
Medical University - Plovdiv, Department of Propedeutics in Internal medicine, Clinic of Rheumatology, Plovdiv - 4002, 15A "Vasil Aprilov" Blvd, Bulgaria.
Curr Rheumatol Rev. 2013;9(4):268-73. doi: 10.2174/157339710904140417125627.
Digital ulcers (DUs) are frequent and recurrent complication in systemic sclerosis (SSc) and are the main cause of pain, impaired function of the hand and disability in SSc. The current study is a retrospective analysis of 60 SSc patients (47 patients with limited cutaneous SSc, 8 patients with diffuse cutaneous SSc and 5 patients with overlap syndrome, mean age 54.5±14.2 years, 52 women and 8 men). The frequency and evolution of DUs as well as the applied therapeutic strategies were analyzed. During the follow-up for a period between 6 months and 6 years, DUs at the fingers were registered in 35% of patients (21/60), more often in patients with diffuse cutaneous SSc (75%, 6/8) as compared with patients with limited cutaneous SSc (29%, 14/47, p<0.05) and overlap syndrome (20%, 1/5). The most frequently observed DUs were ischemic lesions at the fingerpads (85.7%, 18/21) and ulcerations over bony prominences of the fingers (23%, 5/21), which may be found simultaneously. More rare types of DUs were necrotic lesions (14%, 3/21). Thirty-eight percents (8/21) of the patients with DUs showed signs of inflammation. In one patient (4.76%, 1/21) an osteomyelitis developed and an amputation of a finger's distal phalanx was performed. DUs at the toes were significantly less frequent as compared with DUs at the fingers (10%, 6/60, p<0.05). The period of healing of the DUs is prolonged and in the studied group was 3.39±2.39 months. The treatment regimen in SSc patients with DUs included vasodilators, local antiseptic treatment, antiplatelet drug; anticoagulant in cases with development of necrotic lesions, antibiotics in cases of infection or necrotic lesions, and other symptomatic therapies. In conclusion, DUs are a common complication in SSc and require complex therapeutic measures for achievement of a positive outcome.
指端溃疡(DUs)是系统性硬化症(SSc)中常见且反复出现的并发症,是SSc患者疼痛、手部功能受损及残疾的主要原因。本研究对60例SSc患者进行回顾性分析(47例局限性皮肤型SSc患者、8例弥漫性皮肤型SSc患者和5例重叠综合征患者,平均年龄54.5±14.2岁,52例女性,8例男性)。分析了指端溃疡的发生频率、演变情况以及所采用的治疗策略。在6个月至6年的随访期间,35%(21/60)的患者出现手指指端溃疡,弥漫性皮肤型SSc患者(75%,6/8)比局限性皮肤型SSc患者(29%,14/47,p<0.05)和重叠综合征患者(20%,1/5)更常出现。最常见的指端溃疡是指腹缺血性病变(85.7%,18/21)和手指骨隆突处溃疡(23%,5/21),二者可能同时出现。较少见的指端溃疡类型是坏死性病变(14%,3/21)。38%(8/21)的指端溃疡患者有炎症迹象。1例患者(4.76%,1/21)发生骨髓炎,进行了手指远端指骨截肢术。与手指指端溃疡相比,足趾指端溃疡明显较少见(10%,6/60,p<0.05)。指端溃疡愈合期延长,研究组为3.39±2.39个月。SSc合并指端溃疡患者的治疗方案包括血管扩张剂、局部抗菌治疗、抗血小板药物;坏死性病变患者使用抗凝剂,感染或坏死性病变患者使用抗生素,以及其他对症治疗。总之,指端溃疡是SSc常见并发症,需要采取综合治疗措施以取得良好疗效。